Trial
NCT01334892
L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Pari Pharma GmbH
Collaborators
—
Condition
Bronchiolitis Obliterans
Intervention
Cyclosporine Inhalation Solution
Why stopped
Interim analysis results revealed substantial increase of patient number, with unfeasible study prolongation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-04-14